Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL27578591 | 1.00 | FFAR3 (0.54) | — | |
| SCHEMBL11121864 | 0.92 | ALDH1A1 (0.50) | — | |
| SCHEMBL114562 | 0.92 | — | — | |
| Benzene SCHEMBL27283266 | 0.89 | ALDH1A1 (0.41) | — | |
| SCHEMBL23149810 | 0.88 | — | — | |
| Methane SCHEMBL3149754 | 0.88 | — | — | |
| Ammonia Solution, Strong SCHEMBL11198425 | 0.88 | — | — | |
| SCHEMBL5683258 | 0.88 | — | — | |
| Hydrochloric Acid SCHEMBL10945721 | 0.88 | — | — | |
| Ethane SCHEMBL8468937 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1526843-A1 | METHOD OF PREPARING SOLID DOSAGE FORMS COATED IN TWO LAYERS COMPRISING A WATER-INSOLUBLE POLYMER AND A WATER-SOLUBLE PORE FORMER | Pharmacia Corporation (US) | 2005-05-04 | — | — | EP | claimed |
| WO-2004010982-A1 | METHOD OF PREPARING SOLID DOSAGE FORMS COATED IN TWO LAYERS COMPRISING A WATER-INSOLUBLE POLYMER AND A WATER-SOLUBLE PORE FORMER | PHARMACIA CORPORATION (US) | 2004-02-05 | — | — | WO | claimed |
| WO-2020242253-A1 | NOVEL EMPAGLIFLOZIN DERIVATIVE WHICH IS SGLT-2 INHIBITOR | 동아에스티 주식회사 | 2020-12-03 | — | — | WO | disclosed |
| EP-2236218-B1 | Coating method, coater, and method for manufacturing planographic printing plate | FUJIFILM CORP (JP) | 2014-05-21 | — | — | EP | disclosed |
| US-8445069-B2 | Coating method, coater, and method for manufacturing planographic printing plate | FUJIFILM CORPORATION (JP) | 2013-05-21 | — | — | US | disclosed |
| EP-2236218-A1 | Coating method, coater, and method for manufacturing planographic printing plate | Fujifilm Corporation (JP) | 2010-10-06 | — | — | EP | disclosed |
| US-20100247759-A1 | COATING METHOD, COATER, AND METHOD FOR MANUFACTURING PLANOGRAPHIC PRINTING PLATE | FUJIFILM CORPORATION (JP) | 2010-09-30 | — | — | US | disclosed |
| EP-1170123-B1 | Negative-working planographic printing plate | FUJI PHOTO FILM CO LTD (JP) | 2006-09-20 | — | — | EP | disclosed |
| US-6716566-B2 | CAN BE DIRECTLY RECORDED BASED ON DIGITAL DATA FROM COMPUTERS AND THE LIKE, EXCELLENT IN STORAGE STABILITY, SHOWS NO REDUCTION IN SENSITIVITY WITH THE LAPSE OF TIME, AND HAS EXCELLENT FACE FLATNESS | FUJI PHOTO FILM CO., LTD. (JP) | 2004-04-06 | — | — | US | disclosed |
| US-20030073032-A1 | Can be directly recorded based on digital data from computers and the like, excellent in storage stability, shows no reduction in sensitivity with the lapse of time, and has excellent face flatness | FUJIFILM CORPORATION (JP) | 2003-04-17 | — | — | US | disclosed |
| EP-1170123-A2 | Negative-working planographic printing plate | FUJI PHOTO FILM CO., LTD. (JP) | 2002-01-09 | — | — | EP | disclosed |
| EP-0819107-A4 | 9-SUBSTITUTED PORPHYCENES | CYTOPHARM INC (US) | 2000-09-13 | — | — | EP | disclosed |
| EP-0819107-A1 | 9-SUBSTITUTED PORPHYCENES | CYTOPHARM, INC. (US) | 1998-01-21 | — | — | EP | disclosed |
| US-5637608-A | PHOTODYNAMIC THERAPY | CYTOPHARM, INC. (US) | 1997-06-10 | — | — | US | disclosed |
| WO-1996031451-A1 | 9-SUBSTITUTED PORPHYCENES | CYTOPHARM, INC. (US) | 1996-10-10 | — | — | WO | disclosed |
| EP-0233009-A2 | System for delivering drug with enhanced bioacceptability | ALZA CORPORATION (US) | 1987-08-19 | — | — | EP | disclosed |
| US-4284582-A | REACTING A HALOGENATED DIENE WITH A CYANIDE COMPOUND | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1981-08-18 | — | — | US | disclosed |